Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.63p
   
  • Change Today:
      0.38p
  • 52 Week High: 19.50
  • 52 Week Low: 7.50
  • Currency: UK Pounds
  • Shares Issued: 1,036.78m
  • Volume: 36,637
  • Market Cap: £110.16m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

Traded Action Notifier PriceAmountValue
20-May-25 Buy Martin Diggle 9.00p 44,944 £4,044.96
16-May-25 Buy Martin Diggle 9.00p 402,952 £36,265.68
15-May-25 Buy Martin Diggle 9.00p 49,868 £4,488.12

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 10.63p
Change Today 0.38p
% Change 3.66 %
52 Week High 19.50
52 Week Low 7.50
Volume 36,637
Shares Issued 1,036.78m
Market Cap £110.16m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.5% below the market average6.5% below the market average6.5% below the market average6.5% below the market average6.5% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
27.47% below the market average27.47% below the market average27.47% below the market average27.47% below the market average27.47% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 14-Jul-2025

Time Volume / Share Price
09:23 2,000 @ 10.35p
09:08 33,000 @ 10.29p
08:32 800 @ 10.29p
08:07 6 @ 10.70p
08:06 831 @ 10.29p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page